Clinical Trial Update: Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Rexlemestrocel-L alone or with hyaluronic acid for chronic low back pain due to degenerative disc disease completed; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Low Back Pain

Drugs mentioned

• Hyaluronic acid (hyaluronic acid)
• Rexlemestrocel-L (allogeneic mesenchymal precursor cells)

Snippet

Sponsor: Mesoblast, Ltd. | Conditions: Degenerative Disc Disease | Phase 3 | Status: COMPLETED | Results posted: 2022-01-18